Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.61 |
| ▸ | CNR1 | P21554 | 1/20 | 0.61 |
| ▸ | CNR2 | P34972 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | NAAA | Q02083 | 1/20 | 0.47 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.41 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6670001 | 1.00 | FAAH (0.61) | FAAHCNR1CNR2ALDH1A1LMNA | |
| SCHEMBL28167554 | 1.00 | FAAH (0.61) | FAAHCNR1CNR2ALDH1A1LMNA | |
| SCHEMBL28633265 | 1.00 | FAAH (0.61) | FAAHCNR1CNR2ALDH1A1LMNA | |
| SCHEMBL15427306 | 0.92 | FAAH (0.51) | FAAHCNR1CNR2ALDH1A1LMNA | |
| SCHEMBL6906595 | 0.85 | FAAH (0.65) | FAAHCNR1CNR2ALDH1A1LMNA | |
| SCHEMBL8506453 | 0.85 | FAAH (0.75) | FAAHCNR1CNR2ALDH1A1LMNA | |
| SCHEMBL9986402 | 0.85 | FAAH (0.65) | FAAHCNR1CNR2ALDH1A1LMNA | |
| SCHEMBL8994200 | 0.85 | FAAH (0.65) | FAAHCNR1CNR2ALDH1A1LMNA | |
| SCHEMBL9447664 | 0.85 | FAAH (0.65) | FAAHCNR1CNR2ALDH1A1LMNA | |
| SCHEMBL7945793 | 0.85 | FAAH (0.75) | FAAHCNR1CNR2ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1463823-B1 | METHODS OF INCREASING ENDOGENOUS ERYTHROPOIETIN (EPO) | FIBROGEN INC (US) | 2013-03-06 | — | — | EP | claimed |